Started in 2000 and fully accreditated in 2003 as the first PhD program in Germany according to European standards (ECTS), the MD/PhD program features an interdisciplinary curriculum leading to a PhD thesis after 3-4 years.

The program is a joint venture between the following institutions:

• Hannover Medical School
• Leibniz University Hannover
• Fraunhofer Institute ITEM Hannover
• Helmholtz Centre for Infection Research (HZI) Braunschweig
• TWINCORE (Hannover)
• NIFE (Hannover)

PhD topics cover a broad spectrum, including the following areas:

• Immunology & Infection
• Molecular & Cell Biology
• Hematology & Oncology
• Biochemistry & Structural Biology
• Pathology
• Stem Cell Research

• and many more....(nearly all clinics / institutes doing molecular experimental research are involved ☺)

Faculty: more than 150 scientists (details)

Potential PhD students: Holders of an M.Sc. or equivalent degree in Medicine, Biology, Biochemistry, Biotechnology, Biomedicine etc.

Degree:  you will either receive a PhD or Dr.rer.nat. degree (later only for life scientists)

Medical students/graduates are invited to check MD/PhD education for more clinical training options. Please note that we only award a PhD title (not an "MD/PhD")

What we offer: Interesting projects, in-depth basic science seminars for the first two years, excellent structure and supervision. 

Next application deadline: March 1st, 2027. Online application from December 1st 2026 at

https://hbrs.cloud.opencampus.net/